10.43
-0.54(-4.92%)
Currency In USD
| Previous Close | 10.97 |
| Open | 10.95 |
| Day High | 11.01 |
| Day Low | 10.19 |
| 52-Week High | 15.78 |
| 52-Week Low | 5.45 |
| Volume | 150,257 |
| Average Volume | 212,025 |
| Market Cap | 339.6M |
| PE | -11.22 |
| EPS | -0.93 |
| Moving Average 50 Days | 12.61 |
| Moving Average 200 Days | 8.97 |
| Change | -0.54 |
If you invested $1000 in NeuroPace, Inc. (NPCE) since IPO date, it would be worth $417.87 as of March 14, 2025 at a share price of $10.43. Whereas If you bought $1000 worth of NeuroPace, Inc. (NPCE) shares 3 years ago, it would be worth $1,250.6 as of March 14, 2025 at a share price of $10.43.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
UPDATE – NeuroPace to Present at the Leerink Partners Global Healthcare Conference
GlobeNewswire Inc.
Mar 04, 2025 2:15 AM GMT
MOUNTAIN VIEW, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that its management team will present at the Leerin
NeuroPace to Present at the Leerink Partners Global Healthcare Conference
GlobeNewswire Inc.
Mar 03, 2025 9:05 PM GMT
MOUNTAIN VIEW, Calif. , March 03, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that its management team will present at the Leeri
NeuroPace Completes Repurchase of 5.3 Million Shares of Its Common Stock from KCK Ltd.
GlobeNewswire Inc.
Feb 20, 2025 9:05 PM GMT
MOUNTAIN VIEW, Calif., Feb. 20, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it has completed the previously announced plan to re